Baker Bros. Advisors’s MediWound MDWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-32,286
Closed -$1.56M 107
2018
Q2
$1.56M Hold
32,286
0.01% 97
2018
Q1
$1.18M Hold
32,286
0.01% 99
2017
Q4
$1.01M Hold
32,286
0.01% 107
2017
Q3
$1.21M Hold
32,286
0.01% 104
2017
Q2
$1.54M Hold
32,286
0.01% 92
2017
Q1
$1.49M Hold
32,286
0.01% 93
2016
Q4
$1.03M Hold
32,286
0.01% 107
2016
Q3
$1.74M Hold
32,286
0.02% 100
2016
Q2
$1.78M Hold
32,286
0.02% 102
2016
Q1
$1.82M Buy
32,286
+143
+0.4% +$7.47K 0.02% 104
2015
Q4
$1.92M Hold
32,143
0.02% 107
2015
Q3
$1.72M Hold
32,143
0.02% 109
2015
Q2
$1.59M Hold
32,143
0.01% 113
2015
Q1
$1.63M Hold
32,143
0.01% 112
2014
Q4
$1.5M Hold
32,143
0.02% 104
2014
Q3
$1.42M Hold
32,143
0.02% 94
2014
Q2
$2.56M Buy
+32,143
New +$2.62M 0.03% 86

Other funds holding MDWD

Baker Bros. Advisors's MDWD Position: Q3 2018 in Review

Baker Bros. Advisors sold out of MediWound (MDWD) in Q3 2018, closing a stake of 32,286 shares — an estimated $1.56M sold.

Baker Bros. Advisors first reported a position in MDWD in Q2 2014 and held it in 17 quarters. The position peaked at $2.56M in Q2 2014. 25 funds tracked by Wall St. Rank hold MDWD as of Q3 2018.

  • Baker Bros. Advisors reported no remaining MediWound position as of Q3 2018 after selling out during the quarter.
  • Baker Bros. Advisors sold 32,286 MediWound shares in Q3 2018, an estimated $1.56M.
  • Baker Bros. Advisors first reported a position in MediWound in Q2 2014 and held it in 17 quarters.
  • Baker Bros. Advisors's MediWound position peaked at $2.56M in Q2 2014.
  • 25 funds tracked by Wall St. Rank held MediWound as of Q3 2018.

Based on Baker Bros. Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.